Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer

被引:36
作者
Garcia-Zuazaga, Jorge
Cooper, Kevin D.
Baron, Elma D. [1 ]
机构
[1] Louis Stokes Vet Affairs Med Ctr, Cleveland, OH USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA
关键词
aminolevulinic acid; photodynamic therapy; photosensitizer; skin cancer;
D O I
10.1586/14737140.5.5.791
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Photodynamic therapy is a treatment modality that is developing rapidly and increasing in utilization within various medical specialties, including dermatology. This technique requires the presence of a photosensitizer, light energy and molecular oxygen to selectively destroy pathologic cells. A thorough understanding of photobiology and tissue optics is necessary to correctly and effectively utilize photodynamic therapy in dermatology. Photodynamic therapy has been approved by the US Food and Drug Administration to treat actinic keratoses. In Europe, photodynamic therapy is currently being used in the treatment of actinic keratoses and basal cell carcinoma. Other off-label uses of photodynamic therapy have included cutaneous lesions of Bowen's disease, psoriasis, cutaneous T-cell lymphoma and acne. Most recently, photodynamic therapy has been employed in photorejuvenation. The advantages of photodynamic therapy include the capacity for noninvasive targeted therapy via topical application of the drug and local irradiation of involved areas, as well as the ability to generate excellent cosmetic results with minimal discomfort. This review summarizes the fundamentals of photodynamic therapy and its role in the treatment of cutaneous disorders, particularly skin malignancies.
引用
收藏
页码:791 / 800
页数:10
相关论文
共 48 条
[1]  
BOLGNIA J, 2003, DERMATOLOGY, V2, P2127
[2]   The present and future role of photodynamic therapy in cancer treatment [J].
Brown, SB ;
Brown, EA ;
Walker, I .
LANCET ONCOLOGY, 2004, 5 (08) :497-508
[3]  
Calin Mihaela Antonina, 2004, J Exp Ther Oncol, V4, P247
[4]   Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview [J].
Cappugi, P ;
Campolmi, P ;
Mavilia, L ;
Prignano, F ;
Rossi, R .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (05) :494-502
[5]  
CERBUKOV O, 2000, EURO J DERM, V10, P568
[6]   The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy [J].
Choudry, K ;
Brooke, RCC ;
Farrar, W ;
Rhodes, LE .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (01) :124-130
[7]   Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma [J].
Coors, EA ;
von den Driesch, P .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) :363-367
[8]   Photodynamic therapy for cancer [J].
Dolmans, DEJGJ ;
Fukumura, D ;
Jain, RK .
NATURE REVIEWS CANCER, 2003, 3 (05) :380-387
[9]  
Elman Monica, 2003, J Cosmet Laser Ther, V5, P111, DOI 10.1080/14764170310001276
[10]  
Freeman M, 2003, J Dermatolog Treat, V14, P99, DOI 10.1080/09546630310012118